Inventor · disambiguated record
Davor Frleta
Also filed as: Frleta Davor
3 granted patents·7 pending applications·8 citations·filing 2016–2025
63Inventor score
Top patents by PatentIndex Score
10 records- 0187US10561126B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2018·Granted Feb 18, 2020·5 cites·22 claims
- 0283US10123518B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2016·Granted Nov 13, 2018·3 cites·28 claims
- 0377US2023292721A1Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0474US2025248377A1Non-human animals having a humanized tslp gene, a humanized tslp receptor gene, and/or a humanized il7ra geneREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0569US2024415103A1Vectors, genetically modified cells, and genetically modified non-human animals comprising the sameREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0665US2024102045A1Vectors, genetically modified cells, and genetically modified non-human animals comprising the sameREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0764US2022192165A1Non-human animals having a humanized tslp gene, a humanized tslp receptor gene, and/or a humanized il7ra geneREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 0862US11576356B2Genetically modified non-human animals and methods of use thereofREGENEREN PHARMACEUTICALS INC·Filed 2020·Granted Feb 14, 2023·0 cites·20 claims
- 0952US2023172170A1Non-human animals having a humanized cxcl13 geneREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 1047US2025255282A1Vectors, genetically modified cells, and genetically modified non-human animals comprising the sameREGENERON PHARMA·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Davor Frleta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →